2Ploeg M, Aben KH, Kiemeney L. The present anti future burdenof urinary hladlter cancer in the world [ J]. World J Urol, 2009, 27: 289-293.
3Bubuntzan L, Luca C. MAP4K4 a possi-hie new biomarker in cancer therapy [ J]. ale Universitatii " Alexandru Ioan Cuza" din, 2010, 8: 25-32.
4Wright JH, Wang X, Manning G, et al. The STE20 kinase HGK ls broadly ex- pressed in human tumor cells and can modulate cellular transformation, inva- sion, and adhesion [ J]. Mol Cell Biol, 2003, 23: 2068-2082.
5Liang J J, Wang H, Rashid A, et al. Ex- pression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma [ J ]. Clin Cancer Res, 2008, 14: 7043-7049.
6Liu AW, Cai J, Zhao Xh, et al. ShRNA- targeted MAP4K4 inhilbits hepatocellular carcinoma growth [ J ]. Clin Cancer Res, 2011, 17: 710-720.
7Qiu MH, Qian YM, Zhao XL, el al. Expression and prognoslic significance of MAP4K4 in lung adenocarcinoma. Palhol Res Pract, 2012, 208: 541-548.
8Stein JP LG, Cote R, Groshen S, et al. Radical cystect.my in the treatment of invasive bladder cancer: long-term results in 1,054 patients [J ]. J Clin Oncol, 2001, 19: 666-675.
9Haas DA, Bala K, Biische G, et al. The inflammatory kinase MAPdK4 promotes reactivalion of Kaposi's sarcoma herpesvirus and enhances the invasiveness of infected endothelial cells [ J/ OL]. PLoS Pathog, 2013, 9:e1003737 [2014-04-09]. http:// www.ncbi.nlm.nih.gov/pmc/articles/PMC38207 15.
10Loftus JC, Sang Z, Kloss J, et al. A novel interaction between Pyk2 and MAP4K4 is integrated with glioma cell migration [J/ OL].J Signal Transduct, 2013, 2013:956580 [ 2014-04-09]. http ://dx.doi.org/10. 1155/2013/956580.
